Want to see RMTI full AI Analyst Report?
Rockwell Med (RMTI) Financial Statements
Rockwell Med Financial Overview
Rockwell Med's market cap is currently $28.50M. The company's EPS TTM is $-1.39; its P/E ratio is -5.09; Rockwell Med is scheduled to report earnings on November 12, 2026, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 69.26M | $ 101.49M | $ 83.61M | $ 72.81M | $ 61.93M |
| Gross Profit | $ 11.70M | $ 17.48M | $ 8.70M | $ 4.08M | $ -2.42M |
| Operating Income | $ -4.69M | $ 608.00K | $ -6.67M | $ -16.78M | $ -30.34M |
| EBITDA | $ -2.00M | $ 2.95M | $ -4.69M | $ -16.17M | $ -27.80M |
| Net Income | $ -5.31M | $ -480.00K | $ -8.44M | $ -18.68M | $ -32.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 25.00M | $ 21.60M | $ 10.94M | $ 21.49M | $ 22.44M |
| Total Assets | $ 57.15M | $ 59.21M | $ 52.17M | $ 46.63M | $ 48.57M |
| Total Debt | $ 12.47M | $ 13.54M | $ 13.44M | $ 16.36M | $ 28.89M |
| Net Debt | $ 1.76M | $ -2.13M | $ 4.46M | $ 6.26M | $ 15.62M |
| Total Liabilities | $ 20.16M | $ 26.62M | $ 30.88M | $ 32.53M | $ 46.04M |
| Stockholders' Equity | $ 36.98M | $ 32.59M | $ 21.29M | $ 14.11M | $ 2.54M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.20M | $ 3.19M | $ -9.70M | $ -17.21M | $ -34.06M |
| Operating Cash Flow | $ -659.00K | $ 4.20M | $ -9.41M | $ -16.93M | $ -33.53M |
| Investing Cash Flow | $ -8.54M | $ -4.87M | $ -3.04M | $ -2.40M | $ 311.00K |
| Financing Cash Flow | $ 4.25M | $ 7.35M | $ 11.34M | $ 16.15M | $ -2.18M |
Currency in USD